-
1
-
-
0025153828
-
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: A substudy of the Studies of Left Ventricular Dysfunction (SOLVD)
-
Francis G.S., Benedict C., Johnstone D.E., Kirlin P.C., Nicklas J., Liang C.S., Kubo S.H., Rudin-Toretsky E., Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure a substudy of the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation. 82:1990;1724-1729.
-
(1990)
Circulation
, vol.82
, pp. 1724-1729
-
-
Francis, G.S.1
Benedict, C.2
Johnstone, D.E.3
Kirlin, P.C.4
Nicklas, J.5
Liang, C.S.6
Kubo, S.H.7
Rudin-Toretsky, E.8
Yusuf, S.9
-
2
-
-
0029072884
-
Effects of long term therapy on neurohormones in patients with left ventricular dysfunction
-
Benedict C., Francis G.S., Johnstone D.E., Kubo S.H., Kirlin P., Nicklas J., Liang C., Konstam M.A., Greenberg B., Yusuf S. Effects of long term therapy on neurohormones in patients with left ventricular dysfunction. Am J Cardiol. 75:1995;1151-1157.
-
(1995)
Am J Cardiol
, vol.75
, pp. 1151-1157
-
-
Benedict, C.1
Francis, G.S.2
Johnstone, D.E.3
Kubo, S.H.4
Kirlin, P.5
Nicklas, J.6
Liang, C.7
Konstam, M.A.8
Greenberg, B.9
Yusuf, S.10
-
3
-
-
0026704692
-
Effects of the angiotensin-converting enzyme inhibitor, enalapril, on the long-term progression of left ventricular dysfunction in patients with heart failure
-
Konstam M.A., Rousseau M.F., Kronenberg M.W., Udelson J.E., Melin J., Stewart D., Dolan N., Edens T.R., Ahn S., Kinan D., et al. Effects of the angiotensin-converting enzyme inhibitor, enalapril, on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation. 86:1992;431-438.
-
(1992)
Circulation
, vol.86
, pp. 431-438
-
-
Konstam, M.A.1
Rousseau, M.F.2
Kronenberg, M.W.3
Udelson, J.E.4
Melin, J.5
Stewart, D.6
Dolan, N.7
Edens, T.R.8
Ahn, S.9
Kinan, D.10
-
4
-
-
0034609521
-
Progress in heart failure management? Lessons from the real world
-
Konstam M.A. Progress in heart failure management? Lessons from the real world. Circulation. 102:2000;1076-1078.
-
(2000)
Circulation
, vol.102
, pp. 1076-1078
-
-
Konstam, M.A.1
-
5
-
-
0023266532
-
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
-
Effects of enalapril on mortality in severe congestive heart failure results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 316:1987;1429-1435.
-
(1987)
N Engl J Med
, vol.316
, pp. 1429-1435
-
-
-
6
-
-
0025913812
-
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
-
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
-
(1991)
N Engl J Med
, vol.325
, pp. 293-302
-
-
-
7
-
-
0026785561
-
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
-
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
-
(1992)
N Engl J Med
, vol.327
, pp. 685-691
-
-
-
8
-
-
0025770138
-
A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
-
Cohn J.N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W.B., Loeb H., Wong M., et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 325:1991;303-310.
-
(1991)
N Engl J Med
, vol.325
, pp. 303-310
-
-
Cohn, J.N.1
Johnson, G.2
Ziesche, S.3
Cobb, F.4
Francis, G.5
Tristani, F.6
Smith, R.7
Dunkman, W.B.8
Loeb, H.9
Wong, M.10
-
9
-
-
0034688194
-
Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
-
Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., Dagenais G. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 342:2000;145-153.
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
Bosch, J.4
Davies, R.5
Dagenais, G.6
-
10
-
-
0030902115
-
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan In The Elderly study, ELITE)
-
Pitt B., Segal R., Martinez F.A., Meurers G., Cowley A.J., Thomas I., Deedwania P.C., Ney D.E., Snavely D.B., Chang P.I. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan In The Elderly study, ELITE). Lancet. 349:1997;747-752.
-
(1997)
Lancet
, vol.349
, pp. 747-752
-
-
Pitt, B.1
Segal, R.2
Martinez, F.A.3
Meurers, G.4
Cowley, A.J.5
Thomas, I.6
Deedwania, P.C.7
Ney, D.E.8
Snavely, D.B.9
Chang, P.I.10
-
11
-
-
0035818884
-
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure
-
Cohn J.N., Tognoni G. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med. 345:2001;1667-1675.
-
(2001)
N Engl J Med
, vol.345
, pp. 1667-1675
-
-
Cohn, J.N.1
Tognoni, G.2
-
12
-
-
0032834737
-
Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM): Rationale and design. CHARM Programme Investigators
-
Swedberg K., Pfeffer M., Granger C., Held P., McMurray J., Ohlin G., Olofsson B., Ostergren J., Yusuf S. Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM): rationale and design. CHARM Programme Investigators. J Card Fail. 5:1999;276-282.
-
(1999)
J Card Fail
, vol.5
, pp. 276-282
-
-
Swedberg, K.1
Pfeffer, M.2
Granger, C.3
Held, P.4
McMurray, J.5
Ohlin, G.6
Olofsson, B.7
Ostergren, J.8
Yusuf, S.9
-
13
-
-
0033517302
-
The effect of spironolactone on morbidity and mortality in patients with severe heart failure
-
Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., Palensky J., Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 341:1999;709-717.
-
(1999)
N Engl J Med
, vol.341
, pp. 709-717
-
-
Pitt, B.1
Zannad, F.2
Remme, W.J.3
Cody, R.4
Castaigne, A.5
Perez, A.6
Palensky, J.7
Wittes, J.8
-
14
-
-
0029937949
-
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
-
Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
-
(1996)
N Engl J Med
, vol.334
, pp. 1349-1355
-
-
Packer, M.1
Bristow, M.R.2
Cohn, J.N.3
Colucci, W.S.4
Fowler, M.B.5
Gilbert, E.M.6
Shusterman, N.H.7
-
15
-
-
0033514046
-
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
-
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) a randomised trial. Lancet. 353:1999;9-13.
-
(1999)
Lancet
, vol.353
, pp. 9-13
-
-
-
16
-
-
0033549290
-
Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)
-
Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 353:1999;2001-2007.
-
(1999)
Lancet
, vol.353
, pp. 2001-2007
-
-
-
17
-
-
0035978763
-
Effect of carvedilol on survival in severe chronic heart failure
-
Packer M., Coats A.J., Fowler M.B., Katus H.A., Krum H., Mohacsi P., Rouleau J.L., Tendera M., Castaigne A., Roecker E.B., Schultz M.K., DeMets D.L. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 344:2001;1651-1658.
-
(2001)
N Engl J Med
, vol.344
, pp. 1651-1658
-
-
Packer, M.1
Coats, A.J.2
Fowler, M.B.3
Katus, H.A.4
Krum, H.5
Mohacsi, P.6
Rouleau, J.L.7
Tendera, M.8
Castaigne, A.9
Roecker, E.B.10
Schultz, M.K.11
DeMets, D.L.12
-
18
-
-
0031051347
-
The effect of digoxin on mortality and morbidity in patients with heart failure
-
The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 336:1997;525-533.
-
(1997)
N Engl J Med
, vol.336
, pp. 525-533
-
-
-
19
-
-
0037143601
-
Comparison of omapatrilat and enalapril in patients with chronic heart failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)
-
Packer M., Califf R.M., Konstam M.A., Krum H., McMurray J.J., Rouleau J.L., Swedberg K. Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE). Circulation. 106:2002;R21-R27.
-
(2002)
Circulation
, vol.106
-
-
Packer, M.1
Califf, R.M.2
Konstam, M.A.3
Krum, H.4
McMurray, J.J.5
Rouleau, J.L.6
Swedberg, K.7
-
20
-
-
0035856509
-
Acute hemodynamic effects of conivaptan, a dual V1A and V2 vasopressin receptor antagonist, in patients with advanced heart failure
-
Udelson J.E., Smith W.B., Hendrix G.H., Painchaud C.A., Ghazzi M., Thomas I., Ghali J.K., Selaru P., Chanoine F., Pressler M.L., Konstam M.A. Acute hemodynamic effects of conivaptan, a dual V1A and V2 vasopressin receptor antagonist, in patients with advanced heart failure. Circulation. 104:2001;2417-2423.
-
(2001)
Circulation
, vol.104
, pp. 2417-2423
-
-
Udelson, J.E.1
Smith, W.B.2
Hendrix, G.H.3
Painchaud, C.A.4
Ghazzi, M.5
Thomas, I.6
Ghali, J.K.7
Selaru, P.8
Chanoine, F.9
Pressler, M.L.10
Konstam, M.A.11
|